All studies
RecruitingOBSERVATIONAL

Haemdall: Developing a Quantitative MRI Biomarker of Infratentorial Superficial Siderosis of the Central Nervous System

The Haemdall study is exploring a new way to use MRI scans to measure iron deposits on the surface of the brain. These iron deposits are thought to be important in how Superficial Siderosis develops. Researchers also want to find out if the amount of iron in the brain is connected to common symptoms of Superficial Siderosis. To do this, participants will have tests to check their hearing, walking and balance, and their ability to remember, think, and understand things. The aim is to better understand this condition and potentially find new ways to monitor its progression. This study includes both people with Superficial Siderosis and healthy volunteers.

At a glance

Status
Recruiting
Sponsor
Perspectum
Enrolment target
50
Start
14 Aug 2025
Estimated completion
31 Dec 2026

What is this study about?

This study, named Haemdall, is focusing on a condition called Superficial Siderosis. We know that in this condition, iron can build up on the surface of the brain. Doctors believe this iron plays a role in how the condition progresses and the symptoms people experience.

The main goal of this study is to develop a new and more accurate way to measure this iron using special types of MRI scans. By getting a clearer picture of how much iron is there, researchers hope to better understand the disease. They also want to explore if there's a direct link between the amount of iron present and the symptoms observed in people with Superficial Siderosis. Symptoms can include problems with hearing, balance, and even memory or thinking skills.

Ultimately, by learning more about this link, doctors could potentially find better ways to track the condition's progress and perhaps develop new treatments in the future. This study is an important step towards better understanding and managing Superficial Siderosis.

Key takeaways

  • The study aims to improve how we measure iron in the brain using MRI scans.
  • It will investigate the link between iron levels and common symptoms of Superficial Siderosis.
  • It includes both people with Superficial Siderosis and healthy volunteers.
  • Participation involves MRI scans and tests for hearing, balance, and memory.
  • You must be able to have an MRI scan safely to take part.
  • The study doesn't involve new medicines but seeks to advance understanding of the condition.

Who may be eligible?

To take part in the study, you need to be an adult, aged 18 or over. If you have been diagnosed with Superficial Siderosis, you may be able to join. We are also looking for healthy volunteers who do not have any brain or nerve conditions.

It's important that you can understand the study information and speak good enough English to communicate with the study team. You'll also need to be able to read and sign a consent form, showing you agree to take part.

There are some reasons you wouldn't be able to join, mainly if you can't have an MRI scan. This includes if you are pregnant, have a pacemaker, certain metal implants (like shrapnel), or severe claustrophobia. We also can't include anyone with another serious health condition that might affect the study results or put them at risk.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Are you 18 years old or older?
  2. Do you have a confirmed diagnosis of Superficial Siderosis, or are you a healthy adult without neurological issues?
  3. Can you comfortably understand and speak English?
  4. Can you safely have an MRI scan (e.g., no pacemaker, certain metal implants, or severe claustrophobia)?
  5. Are you able and willing to give your informed consent to participate?
Answer every question to see your result.

What does participation involve?

This section is not detailed in the provided brief summary. For comprehensive information on study participation, including the number of visits, specific assessments, whether medication is involved, follow-up procedures, and the total duration, you would need to consult the detailed study protocol or speak directly with the research team. Typically, studies like this often involve at least one MRI scan appointment and several clinical assessments to measure symptoms. You should expect to have tests for hearing, balance, and memory/thinking skills.

Potential risks and benefits

Taking part in a study like this might not directly benefit you, but the information gained could help improve understanding and treatment for Superficial Siderosis in the future. The main potential risk is related to the MRI scan itself, which is a common and generally safe procedure. However, if you have claustrophobia or certain metal implants, an MRI scan might not be safe for you. If you experience any discomfort or concerns during the study, you have the right to withdraw at any time without affecting your usual medical care.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • Perspectum
    Verified postcode
    Oxford, United Kingdom· Recruiting

Common questions

What is Superficial Siderosis?

It's a rare condition where iron builds up on the surface of the brain and spinal cord, which can lead to various symptoms like hearing or balance problems.

Why is this study measuring iron in the brain?

Researchers believe iron buildup is important in how Superficial Siderosis develops, and measuring it could help track the disease and understand its symptoms better.

What is an MRI scan?

An MRI scan uses powerful magnets and radio waves to create detailed pictures of the inside of your body, including your brain. It does not use X-rays.

Will I get any medication in this study?

The information provided suggests this study focuses on scans and tests, not medication. Always ask the study team for full details.

Is there any cost for me to take part?

Clinical trials generally cover the costs of study-related visits and procedures. You should confirm this with the study team.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "Haemdall: Developing a Quantitative MRI Biomarker of Infrate…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.